title: Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases.
authors.forename: Peter Arne
authors.initials: PA
authors.lastname: Gerber
authors.forename: Edwin
authors.initials: E
authors.lastname: Bölke
authors.forename: Bettina Alexandra
authors.initials: BA
authors.lastname: Buhren
authors.forename: Daniela
authors.initials: D
authors.lastname: Bruch-Gerharz
authors.forename: Roland
authors.initials: R
authors.lastname: Fenk
authors.forename: Julia
authors.initials: J
authors.lastname: Reifenberger
authors.forename: Wilfried
authors.initials: W
authors.lastname: Budach
authors.forename: Rainer
authors.initials: R
authors.lastname: Haas
authors.forename: Bernhard
authors.initials: B
authors.lastname: Homey
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003875:Drug Eruptions / Q000209:etiology* / Q000517:prevention & control*; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib